8.09
-0.12
(-1.46%)
At close: 5:35:13 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
149,485.00
93,485.00
155,102.00
233,852.00
112,757.00
Investing Cash Flow
-23,559.00
-122,559.00
-68,543.00
-57,255.00
-23,517.00
Financing Cash Flow
-32,695.00
168,205.00
-45,122.00
-134,878.00
-40,866.00
End Cash Position
--
387,954.00
248,823.00
207,386.00
165,667.00
Capital Expenditure
-172,104.00
-159,304.00
-116,480.00
-71,152.00
-76,526.00
Issuance of Capital Stock
124.00
197,924.00
46.00
--
--
Issuance of Debt
--
--
--
294,411.00
--
Repayment of Debt
--
-10,000.00
-10,000.00
-404,488.00
-16,882.00
Repurchase of Capital Stock
--
--
--
--
-487.00
Free Cash Flow
-22,619.00
-65,819.00
38,622.00
162,700.00
36,231.00
12/31/2020 - 6/20/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FAE.MC Faes Farma, S.A.
3.4300
-1.58%
RJF.MC Laboratorio Reig Jofre, S.A.
2.5600
-1.92%
29A.SG Amphastar Pharmaceuticals Inc
36.20
+3.08%
068760.KQ Celltrion Pharm, Inc.
56,300.00
-1.05%
0ET.MU Esperion Therapeutics Inc
2.1980
+2.66%
R9U2.F Green Thumb Industries Inc.
7.20
-2.90%
VIA.DE Viatris Inc.
11.46
+0.92%
SHMN SOHM, Inc.
0.0007
0.00%
CEL.L Celadon Pharmaceuticals Plc
16.00
0.00%
TEV.F Teva Pharmaceutical Industries Limited
20.20
-0.49%